Vericel Corporation (NASDAQ:VCEL)

CAPS Rating: 1 out of 5

The regenerative medicine company engaged in clinical development of autologous cell products for the repair or regeneration of multiple human tissues, based on proprietary Tissue Repair Cell Technology.

VCEL News and Commentary

Caps

How do you think VCEL will perform against the market?

Add Stock to CAPS Watchlist

All Players

107 Outperform
28 Underperform
 

All-Star Players

8 Outperform
12 Underperform
 

Wall Street

5 Outperform
0 Underperform
 

Top VCEL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

AndrewGreenBull (96.16)
Submitted March 10, 2014

Earning will be released on Mar 13, phase 2 data of ixmyelocel-T for the treatment of dilated cardiomyopathy (DCM) probably will be released at the same time. It is due to release… More

zzlangerhans (99.83)
Submitted December 16, 2016

I'm a little late with my Vericel underperform pitch because I've been busy as Hell with real life short trades and making real money. It's been a good couple of days with Vericel, Brainstorm, Catalyst, and XBiotech eating some serious dirt after… More

VCEL VS S&P 500 (SPY)

Fools bullish on VCEL are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about VCEL.

Recs

0
Member Avatar Lakired (< 20) Submitted: 9/22/2017 6:44:57 PM : Outperform Start Price: $3.70 VCEL Score: +9.41

VCEL is a buy on the strength of its growing MACI pipeline alone, but an extremely strong buy with two catalysts shortly upcoming. A licensing agreement with ICT to bring VCEL's innovations to the Chinese (and greater Asian) market will be processed in the very near future resulting in an influx of cash. The second catalyst is an anticipated green light from the FDA for accelerated approval of ixCELL. I got in at 3.6, but even at (or just under) 5 (and likely into the 6s) this is still a phenomenal investment with growth potential into the teens by 2018.

Recs

0
Member Avatar denniscerny (< 20) Submitted: 5/15/2017 9:36:01 AM : Outperform Start Price: $2.65 VCEL Score: +51.51

Strong pipeline and positive developments.

Recs

0
Member Avatar SmartAce (99.94) Submitted: 11/29/2016 3:31:53 PM : Underperform Start Price: $2.51 VCEL Score: -50.91

My extra sensitive toothpaste doesn’t like it when I use other toothpastes.

Leaderboard

Find the members with the highest scoring picks in VCEL.

Score Leader

snowdust

snowdust (24.44) Score: +236.73

The Score Leader is the player with the highest score across all their picks in VCEL.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
snowdust 24.44 7/2/2010 12/29/2010 Underperform 1Y $27.60 -84.78% +151.95% +236.73 0 Comment
longtermgrowth09 < 20 8/3/2010 Underperform 5Y $31.80 -86.79% +128.58% +215.38 0 Comment
HunterNumber9 73.09 11/17/2010 Underperform 5Y $85.00 -95.06% +117.50% +212.56 0 Comment
zokes10 28.92 11/12/2010 Underperform NS $82.60 -94.92% +113.85% +208.76 0 Comment
zokes101 29.71 11/12/2010 Underperform NS $82.20 -94.89% +113.78% +208.67 0 Comment
foolishmred 62.30 11/15/2010 Underperform 5Y $82.18 -94.89% +113.12% +208.01 0 Comment
BadCopNoDonuts < 20 11/15/2010 Underperform 5Y $80.60 -94.79% +113.18% +207.97 0 Comment
brandonprice1973 63.14 10/25/2011 Underperform 5Y $53.20 -92.11% +106.84% +198.95 0 Comment
leemanschmidt 93.56 11/8/2006 Underperform 3W $256.00 -98.36% +97.28% +195.64 0 Comment
RipeStocksFool 60.74 12/2/2011 Underperform 3M $42.20 -90.05% +103.86% +193.91 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackUltraLong < 20 10/10/2012 Outperform NS $30.00 -86.00% +78.33% -164.33 1 Comment
trackwbbsecuriti < 20 4/16/2012 Outperform NS $45.00 -90.67% +86.53% -177.19 0 Comment
TrackJMP 84.66 9/22/2011 Outperform NS $49.40 -91.50% +125.46% -216.95 0 Comment
trackglobalhunte < 20 8/12/2011 Outperform NS $46.80 -91.03% +117.15% -208.18 0 Comment
TrackStifel 93.55 3/28/2011 Outperform NS $47.60 -91.18% +95.40% -186.58 0 Comment
trackwbbsecuriti < 20 2/9/2011 Underperform NS $53.20 -18.42% -4.47% +13.95 12/6/2011 @ $43.40 0 Comment

Featured Broker Partners